Coherus Oncology, Inc. short interest in 2023
In 2023, Coherus Oncology, Inc.'s disclosed short interest ran from 13.07% of shares outstanding on 13 Jan 2023 to 21.75% on 29 Dec 2023, a change of +8.68 percentage points. The year's high was 21.75% on 29 Dec 2023 and its low 12.27% on 31 Jan 2023, averaging 16.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.00 days on 28 Apr 2023. Full history: Coherus Oncology, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 13.07% (13 Jan 2023)
- End of year
- 21.75% (29 Dec 2023)
- Change
- +8.68 pp
- High
- 21.75% (29 Dec 2023)
- Low
- 12.27% (31 Jan 2023)
- Average
- 16.30%
- Highest days to cover
- 15.00 (28 Apr 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 13.07% | 5.78 | |
| 31 Jan 2023 | 12.27% | 10.52 | |
| 15 Feb 2023 | 12.54% | 12.46 | |
| 28 Feb 2023 | 12.66% | 10.99 | |
| 15 Mar 2023 | 15.50% | 8.12 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 15.24% | 11.10 | |
| 14 Apr 2023 | 14.13% | 11.64 | |
| 28 Apr 2023 | 13.56% | 15.00 | |
| 15 May 2023 | 14.77% | 6.16 | 10-Q filed, results (8-K) |
| 31 May 2023 | 16.16% | 3.22 | |
| 15 Jun 2023 | 16.18% | 3.54 | |
| 30 Jun 2023 | 18.67% | 2.60 | |
| 14 Jul 2023 | 15.61% | 3.15 | |
| 31 Jul 2023 | 14.24% | 6.08 | |
| 15 Aug 2023 | 16.62% | 5.50 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 16.57% | 10.18 | |
| 15 Sep 2023 | 15.38% | 2.83 | |
| 29 Sep 2023 | 18.63% | 6.76 | |
| 13 Oct 2023 | 19.82% | 7.64 | |
| 31 Oct 2023 | 17.81% | 3.98 | |
| 15 Nov 2023 | 19.47% | 2.93 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 19.27% | 5.78 | |
| 15 Dec 2023 | 21.35% | 5.66 | |
| 29 Dec 2023 | 21.75% | 1.79 |
See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.